Regulus Therapeutics' (RGLS) RG-012 Receives Orphan Designation from EC
Tweet Send to a Friend
Regulus Therapeutics (NASDAQ: RGLS) announced that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE